Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell DiseaseCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Vaso-Occlusive Crises, acute chest syndrome, agnosia, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, lung disorder, nervous system disorder, perceptual disorders, respiratory system disorder, sickle cell diseaseRecruitingPhase 32026-09-09NCT07274254

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Nantes University Hospital223

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
CHRU Tours - Hôpital BretonneauToursFrance3
CHU BordeauxBordeauxFrance67
CHU de Bordeaux - Hôpital Saint-AndréBordeauxFrance2
CHU de NantesNantesFrance60
CHU GuadeloupeLes AbymesGuadeloupe1
CHU La TimoneMarseilleFrance8
CHU LilleLilleFrance63
CHU OrléansOrléansFrance11
CHU PoitiersPoitiersFrance70
CHU RouenRouenFrance49
Hôpital Tenon APHPParisFrance2
Oncopole ToulouseToulouseFrance3